Related Experiment Video
Updated: May 14, 2026

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
Calcium ameliorates diarrhea in immunocompromised children
Sam X Cheng1, Harrison X Bai, Regino Gonzalez-Peralta
1Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA. sam.cheng@ufl.edu
Calcium administration successfully halted severe infectious diarrhea in three immunocompromised children. This finding offers a new therapeutic avenue for managing persistent diarrhea in vulnerable patient populations.
Area of Science:
- Medical Science
- Pediatrics
- Infectious Diseases
Background:
- Infectious diarrhea is a significant challenge, especially in immunocompromised patients, often leading to severe and prolonged symptoms.
- Current treatments like rehydration therapy address fluid loss but do not stop the diarrhea itself.
- There is an ongoing need for safe and effective methods to ameliorate diarrhea.
More Related Videos
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

